DK559989D0 - Farmaceutisk praeparat til perkutan indgivelse med indhold af bunazosin eller et salt deraf - Google Patents

Farmaceutisk praeparat til perkutan indgivelse med indhold af bunazosin eller et salt deraf

Info

Publication number
DK559989D0
DK559989D0 DK559989A DK559989A DK559989D0 DK 559989 D0 DK559989 D0 DK 559989D0 DK 559989 A DK559989 A DK 559989A DK 559989 A DK559989 A DK 559989A DK 559989 D0 DK559989 D0 DK 559989D0
Authority
DK
Denmark
Prior art keywords
percutaneous administration
salt
pharmaceutical preparation
administration containing
bunazosin
Prior art date
Application number
DK559989A
Other languages
English (en)
Other versions
DK559989A (da
Inventor
Mitsuhiro Yoshida
Hiroyuki Fujimori
Hidenori Asakawa
Masayoshi Kasai
Masanori Kayano
Shigemitsu Osawa
Original Assignee
Eisai Co Ltd
Sansho Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd, Sansho Co filed Critical Eisai Co Ltd
Publication of DK559989D0 publication Critical patent/DK559989D0/da
Publication of DK559989A publication Critical patent/DK559989A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
DK559989A 1988-11-11 1989-11-09 Farmaceutisk praeparat til perkutan indgivelse med indhold af bunazosin eller et salt deraf DK559989A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63285428A JP2794022B2 (ja) 1988-11-11 1988-11-11 ブナゾシン或いはその塩類含有経皮適用製剤

Publications (2)

Publication Number Publication Date
DK559989D0 true DK559989D0 (da) 1989-11-09
DK559989A DK559989A (da) 1990-05-12

Family

ID=17691396

Family Applications (1)

Application Number Title Priority Date Filing Date
DK559989A DK559989A (da) 1988-11-11 1989-11-09 Farmaceutisk praeparat til perkutan indgivelse med indhold af bunazosin eller et salt deraf

Country Status (11)

Country Link
US (1) US5041437A (da)
EP (1) EP0368339B1 (da)
JP (1) JP2794022B2 (da)
AT (1) ATE90873T1 (da)
AU (1) AU615115B2 (da)
CA (1) CA2001574A1 (da)
DE (1) DE68907312T2 (da)
DK (1) DK559989A (da)
ES (1) ES2057064T3 (da)
FI (1) FI92149C (da)
NO (1) NO176082C (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2112751A1 (en) * 1991-07-03 1993-01-21 Charles J. Ii Betlach Composition and method for transdermal delivery of diclofenac
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
EP0721348B1 (en) * 1993-09-29 1999-09-01 Alza Corporation Monoglyceride/lactate ester permeation enhancer
US5420106A (en) * 1994-03-22 1995-05-30 Bristol-Myers Squibb Company Method and composition having enhanced alpha-hydroxy acid skin permeation and retention
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
GB2301878A (en) * 1995-06-06 1996-12-18 Hardware & Systems Patents Ltd Ventilator:mounting
ATE322889T1 (de) † 1999-02-08 2006-04-15 Alza Corp Stabile nicht wässerige einphasige visköse vehikeln und formulierungen die diese vehikeln verwenden
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
JP5143131B2 (ja) 2006-05-30 2013-02-13 インターシア セラピューティクス，インコーポレイティド 浸透圧送出システムの二片構成内部チャネル型の流れモジュレータ
PL2359808T3 (pl) 2006-08-09 2013-10-31 Intarcia Therapeutics Inc Osmotyczne systemy dostawcze i zespoły tłokowe
MX2009011123A (es) 2007-04-23 2009-11-02 Intarcia Therapeutics Inc Formulaciones de suspensiones de peptidos insulinotropicos y sus usos.
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
NZ598686A (en) 2009-09-28 2014-05-30 Intarcia Therapeutics Inc Rapid establishment and/or termination of substantial steady-state drug delivery
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
AU2016270984B2 (en) 2015-06-03 2021-02-25 Intarcia Therapeutics, Inc. Implant placement and removal systems
CN109310743A (zh) 2016-05-16 2019-02-05 因塔西亚制药公司 胰高血糖素受体选择性多肽及其使用方法
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
EP3565580B1 (en) 2017-01-03 2024-03-06 i2o Therapeutics, Inc. Continuous administration of exenatide and co-adminstration of acetaminophen, ethinylestradiol or levonorgestrel

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377581A (en) * 1980-03-03 1983-03-22 Pfizer Inc. Chloro- and alkoxy-substituted-2,4-diaminoquinazolines
JPS58225009A (ja) * 1982-06-23 1983-12-27 Shionogi & Co Ltd コルチコステロイド外用製剤
JPS6122512A (ja) * 1984-07-06 1986-01-31 ヤマハ株式会社 ワイヤハ−ネス製造システム用コネクタ−配置ヘッド
JPS6169721A (ja) * 1984-09-13 1986-04-10 Kao Corp 抗真菌組成物
US4925837A (en) * 1984-09-14 1990-05-15 Synthelabo Pharmaceutical compositions
JPS61225122A (ja) * 1985-03-30 1986-10-06 Eisai Co Ltd キナツオリン系化合物含有組成物
JPH0735332B2 (ja) * 1986-02-25 1995-04-19 久光製薬株式会社 外用クリ−ム製剤
JP2521091B2 (ja) * 1986-06-18 1996-07-31 日研化学株式会社 カテコ−ルアミン類の外用製剤
JPH0816066B2 (ja) * 1986-07-18 1996-02-21 エーザイ株式会社 持続性薬効製剤
US4766842A (en) * 1987-04-29 1988-08-30 Jon Long Method and means for wave soldering of leads of an integrated circuit package
JP2563336B2 (ja) * 1987-06-01 1996-12-11 エーザイ株式会社 角膜透過促進点眼剤

Also Published As

Publication number Publication date
DK559989A (da) 1990-05-12
DE68907312D1 (de) 1993-07-29
ES2057064T3 (es) 1994-10-16
FI895045A0 (fi) 1989-10-24
FI92149C (fi) 1994-10-10
EP0368339B1 (en) 1993-06-23
NO176082B (no) 1994-10-24
EP0368339A2 (en) 1990-05-16
NO894465D0 (no) 1989-11-09
JP2794022B2 (ja) 1998-09-03
AU615115B2 (en) 1991-09-19
US5041437A (en) 1991-08-20
CA2001574A1 (en) 1990-05-11
FI92149B (fi) 1994-06-30
NO894465L (no) 1990-05-14
JPH02131426A (ja) 1990-05-21
NO176082C (no) 1995-02-01
AU4384589A (en) 1990-05-17
ATE90873T1 (de) 1993-07-15
EP0368339A3 (en) 1990-12-19
DE68907312T2 (de) 1993-11-25

Similar Documents

Publication Publication Date Title
DK559989A (da) Farmaceutisk praeparat til perkutan indgivelse med indhold af bunazosin eller et salt deraf
ATE15443T1 (de) Essbare, pharmazeutische zusammensetzungen und verfahren zur herstellung.
ATE153854T1 (de) Stabile pharmazeutische zubereitung mit fumagillolderivaten
NZ222333A (en) Phosphonic acid derivatives of alpha-amino-alpha-(3-alkylphenyl)alkyl ethanoic acids and pharmaceutical compositions thereof
KR940005267A (ko) 경피투여용 기제
DK585889A (da) Farmaceutisk praeparat
GB8812653D0 (en) Pharmaceutical composition based on high concentration esters of docosahexaenoic acid
DE3685275D1 (de) Herstellung von 5-fluor-2'-deoxyuridin estern zur intravenoesen verabreichung.
FR2559151B1 (fr) Derives de l'arginine et sels d'addition d'acides correspondants pharmaceutiquement acceptables et compositions pharmaceutiques les contenant
ATE62594T1 (de) Pharmazeutische oder kosmetische zusammensetzung mit gehalt an hydrochinon und kojisaeure in liposomen.
IL82639A0 (en) Transdermal pharmaceutical composition
IE790754L (en) Substituted ethanolamines
JPS5640607A (en) Drug composition
ATE71529T1 (de) Pharmazeutische praeparate zur transdermalen applikation von heparin.
GT198400063A (es) Formulacion en dos faces
IE873107L (en) Oleic acid esters and pharmaceutical compositions

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment